Ligand Pharmaceuticals
LGND
#4139
Rank
NZ$3.76 B
Marketcap
$199.50
Share price
4.47%
Change (1 day)
106.53%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.69. In 2022 the company made an earnings per share (EPS) of -$3.39 a decrease over its 2021 EPS that were of $5.92.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-174.79%
2022-$3.39-157.23%
2021$5.92-2571.43%
2020-$0.24-100.46%
2019$52.40353.48%
2018$11.551025%
2017$1.03-700%
2016-$0.17-100.87%
2015$19.791859.32%
2014$1.015.36%
2013$0.968.0704505322479E+18%
2012$0.0000000000-100%
2011$0.84-194.23%
2010-$0.89548.38%
2009-$0.14-98.7%
2008-$10.58-136.52%
2007$28.96-787.8%
2006-$4.21-14.58%
2005-$4.93-21.31%
2004-$6.26-55.15%
2003-$13.9781.33%
2002-$7.702.74%
2001-$7.50-45.93%
2000-$13.86-14.56%
1999-$16.23-45.52%
1998-$29.78-3.97%
1997-$31.02132.31%
1996-$13.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.22 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.62-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.99 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.12 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.18 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.29 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.80 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.76 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.11 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA